Related references
Note: Only part of the references are listed.Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
Michael A. Nauck
AMERICAN JOURNAL OF MEDICINE (2011)
Endogenous GLP-1 Regulates Postprandial Glycemia in Humans: Relative Contributions of Insulin, Glucagon, and Gastric Emptying
Mathias Nicolaus et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion
Anne-Barbara Witte et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects
Jing Ma et al.
BRITISH JOURNAL OF NUTRITION (2010)
Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: Relationship to glycemia
Adam M. Deane et al.
CRITICAL CARE MEDICINE (2010)
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions
L. Pala et al.
DIABETIC MEDICINE (2010)
Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes
Erin L. St Onge et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia
Adam M. Deane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors
A. Amato et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
P. M. Hellstrom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Diabetic Gastroparesis Diagnosis and Management
Jing Mi et al.
DRUGS (2009)
Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes
M. A. Nauck et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
GLP-1 regulates gastroduodenal motility involving cholinergic pathways
J. Schirra et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans
H. -J. Woerle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study
Adrian Vella et al.
CLINICAL ENDOCRINOLOGY (2008)
Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
Ralph A. DeFronzo et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Regulation of Islet Hormone Release and Gastric Emptying by Endogenous Glucagon-Like Peptide 1 after Glucose Ingestion
Marzieh Salehi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker et al.
LANCET (2008)
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
P. M. Hellstrom et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
Wook Kim et al.
PHARMACOLOGICAL REVIEWS (2008)
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
Helle Linnebjerg et al.
REGULATORY PEPTIDES (2008)
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
Elza Muscelli et al.
DIABETES (2008)
Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance
Kirsten Vollmer et al.
DIABETES (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1
Hyeung-Jin Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men
Amelia N. Pilichiewicz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes
Adrian Vella et al.
DIABETES (2007)
Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release
Reawika Chaikomin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Exenatide - A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea)
Risto S. Cvetkovic et al.
DRUGS (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: Relationships with postprandial glycemic and insulinemic responses
TJ Little et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
MJ Theodorakis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans
J Schirra et al.
GUT (2006)
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed
Tanya J. Little et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly
Diana Gentilcore et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes
A Russo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes
A Mari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects
JJ Meier et al.
DIABETES (2005)
Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats
BR Gedulin et al.
DIABETOLOGIA (2005)
The physiological role of GLP-1 in human:: Incretin, ileal brake or more?
J Schirra et al.
REGULATORY PEPTIDES (2005)
The [pre-] history of the incretin concept
W Creutzfeldt
REGULATORY PEPTIDES (2005)
Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1
S Katsuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects
E Blase et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Postprandial hyperglycemia and diabetes complications - Is it time to treat?
A Ceriello
DIABETES (2005)
Gastric inhibitory polypeptide does not inhibit gastric emptying in humans
JJ Meier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
LL Baggio et al.
DIABETES (2004)
Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes
DG O'Donovan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction
S Delgado-Aros et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2003)
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
JJ Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effect of altering gastric emptying on postprandial plasma glucose concentrations following a Physiologic meal in Type-II diabetic patients
S Gonlachanvit et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication
EP Bouras et al.
GUT (2002)
GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat
A Bozkurt et al.
REGULATORY PEPTIDES (2002)
Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1-and-2-producing neuroendocrine tumor
PL Brubaker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
AJ Kastin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes
CB Juhl et al.
DIABETES (2002)
Effects of glucagon-like peptide-1 (7-36)amide on motility and sensation of the proximal stomach in humans
J Schirra et al.
GUT (2002)
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
E Bonora et al.
DIABETOLOGIA (2001)
Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
MB Toft-Nielsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
T Vilsboll et al.
DIABETES (2001)
Relationships of upper gastrointestinal motor and sensory function with glycemic control
CK Rayner et al.
DIABETES CARE (2001)
Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma
MM Byrne et al.
DIGESTION (2001)
Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans
J Schirra et al.
GUT (2000)
Share Paper
